Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skinvisible Offers Eight-Hour Photostable Sunscreen Composition

This article was originally published in The Tan Sheet

Executive Summary

The research and development firm now offers eight-hour photostability in formulas based on its recently patented composition. Skinvisible’s other formulas are avobenzone-based with photostability of around four hours.

You may also be interested in...



L’Oreal Sues Competitors J&J, Merck For Sunscreen Patent Infringement

L’Oreal says competitors Johnson & Johnson and Merck revealed in previous litigation that both use octocrylene to keep the avobenzone in their sunscreen formulas from degrading, representing two cases of willful patent infringement. L’Oreal is suing the companies in Delaware federal court for injunction and damages.

Croda Plugs Offerings As Sunscreen Rule Compliance Solutions

Ingredient supplier Croda promotes its Solaveil XT-40W titanium dioxide dispersion as an option for green sunscreen marketers looking to meet broad-spectrum protection requirements in FDA’s final rule for OTC sunscreens.

FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

Topics

Related Companies

UsernamePublicRestriction

Register

PS105653

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel